Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value: $192M (100.0% shares, 0.0% debt)

Holdings (33)

XBI SPDR SER TR 15.5%
Value $29.71M Shares 400,000 Share Price $74.27 Est. Cost/Share — Unrealized @ Report Date —
CLDX CELLDEX THERAPEUTICS INC NEW 5.6%
Value $10.78M Shares 400,000 Share Price $26.96 * Est. Cost/Share $28.96 Unrealized @ Report Date +0.3%
FOLD AMICUS THERAPEUTICS INC 5.6%
Value $10.74M Shares 1,000,000 Share Price $10.74 * Est. Cost/Share $11.01 Unrealized @ Report Date -25.2%
APLS APELLIS PHARMACEUTICALS INC 5.3%
Value $10.18M Shares 225,000 Share Price $45.22 Est. Cost/Share $49.72 Unrealized @ Report Date -8.3%
SRPT SAREPTA THERAPEUTICS INC 5.1%
Value $9.745M Shares 130,000 Share Price $74.96 Est. Cost/Share $78.15 Unrealized @ Report Date -5.9%
AXSM AXSOME THERAPEUTICS INC 4.5%
Value $8.618M Shares 225,000 Share Price $38.30 * Est. Cost/Share $31.36 Unrealized @ Report Date +0.8%
COGT COGENT BIOSCIENCES INC 4.2%
Value $8.118M Shares 900,000 Share Price $9.02 * Est. Cost/Share $10.34 Unrealized @ Report Date -34.0%
— HORIZON THERAPEUTICS PUB L 4.2%
Value $7.976M Shares 100,000 Share Price $79.76 Est. Cost/Share $79.76 Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 3.8%
Value $7.384M Shares 110,000 Share Price $67.13 Est. Cost/Share $72.80 Unrealized @ Report Date —
PCVX VAXCYTE INC 3.7%
Value $7.072M Shares 325,000 Share Price $21.76 * Est. Cost/Share $21.83 Unrealized @ Report Date +6.0%
ASND ASCENDIS PHARMA A/S 3.6%
Value $6.972M Shares 75,000 Share Price $92.96 Est. Cost/Share $131.68 Unrealized @ Report Date —
VRDN VIRIDIAN THERAPEUTICS INC 3.6%
Value $6.942M Shares 600,000 Share Price $11.57 * Est. Cost/Share $17.40 Unrealized @ Report Date -22.8%
— SEAGEN INC 3.2%
Value $6.193M Shares 35,000 Share Price $176.94 Est. Cost/Share $176.94 Unrealized @ Report Date —
— KARUNA THERAPEUTICS INC 3.0%
Value $5.693M Shares 45,000 Share Price $126.51 Est. Cost/Share $126.78 Unrealized @ Report Date —
— MERUS N V 2.9%
Value $5.66M Shares 250,000 Share Price $22.64 Est. Cost/Share $29.12 Unrealized @ Report Date —
— IVERIC BIO INC 2.5%
Value $4.81M Shares 500,000 Share Price $9.62 Est. Cost/Share $7.65 Unrealized @ Report Date —
— CTI BIOPHARMA CORP 2.5%
Value $4.776M Shares 800,000 Share Price $5.97 Est. Cost/Share $2.98 Unrealized @ Report Date —
RLMD RELMADA THERAPEUTICS INC 2.5%
Value $4.748M Shares 250,000 Share Price $18.99 * Est. Cost/Share $23.79 Unrealized @ Report Date -8.3%
ARVN ARVINAS INC 2.4%
Value $4.63M Shares 110,000 Share Price $42.09 * Est. Cost/Share $28.07 Unrealized @ Report Date +78.7%
SNDX SYNDAX PHARMACEUTICALS INC 2.3%
Value $4.329M Shares 225,000 Share Price $19.24 * Est. Cost/Share $18.21 Unrealized @ Report Date -8.5%
DSGN DESIGN THERAPEUTICS INC 2.0%
Value $3.85M Shares 275,000 Share Price $14.00 * Est. Cost/Share $15.73 Unrealized @ Report Date -14.1%
— KEZAR LIFE SCIENCES INC 1.9%
Value $3.722M Shares 450,000 Share Price $8.27 Est. Cost/Share $15.75 Unrealized @ Report Date —
XBI SPDR SER TR 1.9%
Value $3.714M Shares 50,000 Share Price $74.28 Est. Cost/Share — Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS INC 1.8%
Value $3.439M Shares 325,000 Share Price $10.58 * Est. Cost/Share $16.04 Unrealized @ Report Date -35.7%
— RAPT THERAPEUTICS INC 1.6%
Value $3.011M Shares 165,000 Share Price $18.25 Est. Cost/Share $33.20 Unrealized @ Report Date —
— DICE THERAPEUTICS INC 1.2%
Value $2.328M Shares 150,000 Share Price $15.52 Est. Cost/Share $15.53 Unrealized @ Report Date —
WHWK AADI BIOSCIENCE INC 1.0%
Value $1.848M Shares 150,000 Share Price $12.32 * Est. Cost/Share $25.11 Unrealized @ Report Date -40.9%
TARS TARSUS PHARMACEUTICALS INC 0.9%
Value $1.752M Shares 120,000 Share Price $14.60 * Est. Cost/Share $31.23 Unrealized @ Report Date -51.9%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 0.8%
Value $1.575M Shares 300,000 Share Price $5.25 * Est. Cost/Share $6.29 Unrealized @ Report Date 0.0%
— 9 METERS BIOPHARMA INC 0.2%
Value $469K Shares 1,800,000 Share Price $0.26 Est. Cost/Share $1.25 Unrealized @ Report Date —
— AEGLEA BIOTHERAPEUTICS INC 0.2%
Value $467K Shares 925,000 Share Price $0.50 Est. Cost/Share $1.84 Unrealized @ Report Date —
— DICE THERAPEUTICS INC 0.2%
Value $466K Shares 30,000 Share Price $15.53 Est. Cost/Share $15.53 Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 0.1%
Value $277K Shares 1,900 Share Price $145.79 * Est. Cost/Share $141.87 Unrealized @ Report Date 0.0%